Related references
Note: Only part of the references are listed.Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
Charlotte Rypens et al.
NPJ BREAST CANCER (2022)
Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database
Hannah Grace Abraham et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Biological Aspects of Cancer Health Disparities
Jennifer A. Freedman et al.
ANNUAL REVIEW OF MEDICINE, VOL 72, 2021 (2021)
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy
Gayathri R. Devi et al.
CANCERS (2021)
Muscleblind-like 2 controls the hypoxia response of cancer cells
Sandra Fischer et al.
RNA (2020)
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer
Jian Carrot-Zhang et al.
CANCER CELL (2020)
A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells
Larisa M. Gearhart-Serna et al.
CARCINOGENESIS (2020)
Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program
Abdi T. Gudina et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
Federico Bocci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
XIAP Regulation by MNK Links MAPK and NF kappa B Signaling to Determine an Aggressive Breast Cancer Phenotype
Myron K. Evans et al.
CANCER RESEARCH (2018)
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
Tamer M. Fouad et al.
PLOS ONE (2018)
Inflammatory breast cancer biology: the tumour microenvironment is key
Bora Lim et al.
NATURE REVIEWS CANCER (2018)
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
Dezheng Huo et al.
JAMA ONCOLOGY (2017)
Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers
Ryan A. Denu et al.
JOURNAL OF CANCER EPIDEMIOLOGY (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
ROBUST HYPERPARAMETER ESTIMATION PROTECTS AGAINST HYPERVARIABLE GENES AND IMPROVES POWER TO DETECT DIFFERENTIAL EXPRESSION
Belinda Phipson et al.
ANNALS OF APPLIED STATISTICS (2016)
X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity
M. K. Evans et al.
CELL DEATH & DISEASE (2016)
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis
Tamer M. Fouad et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence
Tanya Keenan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
Erica T. Warner et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
Jennifer L. Allensworth et al.
MOLECULAR ONCOLOGY (2015)
Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data
Jill K. Schinkel et al.
CANCER CAUSES & CONTROL (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
Protocadherin-7 induces bone metastasis of breast cancer
Ai-Min Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
Jennifer L. Allensworth et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization
Kevin P. Williams et al.
CANCER LETTERS (2013)
Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
Steven J. Van Laere et al.
CLINICAL CANCER RESEARCH (2013)
Immunologic Targeting of FOXP3 in Inflammatory Breast Cancer Cells
Smita Nair et al.
PLOS ONE (2013)
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells
Jagdeep K. Singh et al.
BREAST CANCER RESEARCH (2013)
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells
Katherine M. Aird et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Association of Inflammatory and Noninflammatory Breast Cancer with Socioeconomic Characteristics in the Surveillance, Epidemiology, and End Results Database, 2000-2007
Jennifer A. Schlichting et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
XIAP Inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer Cells
Jennifer L. Allensworth et al.
MOLECULAR CANCER THERAPEUTICS (2012)
What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Dora Il'yasova et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Differences in Survival Among Women With Stage III Inflammatory and Noninflammatory Locally Advanced Breast Cancer Appear Early A Large Population-Based Study
Shaheenah Dawood et al.
CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Racial Differences in Oxidative Stress and Inflammation: In Vitro and In Vivo
Deborah L. Feairheller et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Inflammatory Breast Cancer The Disease, the Biology, the Treatment
Fredika M. Robertson et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells with Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor
Katherine M. Aird et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Steffen Durinck et al.
NATURE PROTOCOLS (2009)
NF-kappa B genes have a major role in Inflammatory Breast Cancer
Florence Lerebours et al.
BMC CANCER (2008)
NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation
S. J. Van Laere et al.
BRITISH JOURNAL OF CANCER (2007)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Nuclear factor-kappa B signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappa B DNA-binding
Steven J. Van Laere et al.
CLINICAL CANCER RESEARCH (2006)
Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute
KW Hance et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer
KL van Golen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Share Paper
